Clinical Trials

19 enrolled 11 charts

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

NCT05275439 2026-03-18

Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

MyeloidOther hematologic neoplasm

106 enrolled 28 charts

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06599502 2026-03-18

ALAFOSS-01

17 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06799533 2026-03-18

A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

11 enrolled

Dermatologic

Melanoma

NCT02478112 2026-03-17

BioPro-RCMI

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT03265496 2026-03-17

CONCORDE

21 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03547115 2026-03-17

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

LymphoidOther hematologic neoplasm

84 enrolled

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

20 enrolled

Other solid neoplasm

Solid Tumor

NCT05351697 2026-03-17

BR105-I

31 enrolled

Advanced Malignancies

NCT01198119 2026-03-16

NBI-CAB

23 enrolled

Head & Neck

Mouth Neoplasms, Neoplasms

NCT01612481 2026-03-16

CASSANDRE

11 enrolled

Sarcoma

NCT02439047 2026-03-16

MESO-PATCH

6 enrolled

Tumor-Agnostic

Neoplasms

NCT02565433 2026-03-16

PRAMECE

52 enrolled

CNS

Brain Neoplasms, Neoplasm Metastasis

NCT03360721 2026-03-16

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

7 enrolled

Genitourinary

Prostatic Neoplasms

NCT03590574 2026-03-16

Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma

20 enrolled 34 charts

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

NCT04347616 2026-03-16

NK4AML

Other hematologic neoplasm

9 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT04904302 2026-03-16

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

15 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05753007 2026-03-16

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

2 enrolled 13 charts

CNS

Glioblastoma

NCT06540066 2026-03-16

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

35 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT00421317 2026-03-13

O-Mel-Inib

13 enrolled

Dermatologic

Melanoma

NCT01641484 2026-03-13

ANOXICOL

9 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT01647477 2026-03-13

DEREDIA

90 enrolled

Head & Neck

Laryngeal Diseases

NCT03652298 2026-03-13

NeuroPrevPTSD

GastrointestinalGenitourinary

19 enrolled

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

NCT04676360 2026-03-13

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

10 enrolled 11 charts

Lymphoid

Plasmablastic Lymphoma

NCT04729387 2026-03-13

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Phase 3 Terminated

358 enrolled

Gynecologic

Ovarian Neoplasms

NCT05479123 2026-03-13

Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas

Phase 4 Terminated

52 enrolled 24 charts

Hemangioma, Capillary

NCT05935098 2026-03-13

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

99 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06038539 2026-03-13

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Phase 3 Terminated

55 enrolled

Breast

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients

NCT06083454 2026-03-13

Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)

1 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06173505 2026-03-13

Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

37 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT03386357 2026-03-12

Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

115 enrolled 15 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04221438 2026-03-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

3 enrolled 11 charts

Dermatologic

Lymphatic Metastasis, Melanoma

NCT04796324 2026-03-12

Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.

13 enrolled 8 charts

Breast

Breast Neoplasms

NCT05744375 2026-03-12

TRANSCENDER

2 enrolled 10 charts

Breast

Breast Neoplasms

NCT05994157 2026-03-12

Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

1 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT03694015 2026-03-11

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

160 enrolled

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Pathologic Processes

NCT03753919 2026-03-11

DUTHY

79 enrolled 25 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT04832854 2026-03-11

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

50 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT02780128 2026-03-10

NEPENTHE

66 enrolled

CNS

Neoplasms, Neuroblastoma

NCT03404193 2026-03-10

Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

235 enrolled

Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04166383 2026-03-10

VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)

14 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

5 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05537766 2026-03-10

ZUMA-25